Crossmark

Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives

Crossref DOI link: https://doi.org/10.1007/s00726-024-03397-3

Published Online: 2024-05-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aslan, Ayca https://orcid.org/0000-0001-8105-7970
Ari Yuka, Selcen https://orcid.org/0000-0002-0028-2453
License Information

Text and Data Mining valid from 2024-05-31

Version of Record valid from 2024-05-31
More Information

Article History

Received: 25 January 2024

Accepted: 6 May 2024

First Online: 31 May 2024

Declarations

:

: A.A. and S.A.Y. have no conflicts of interest or financial ties to disclose.

: Not applicable.